Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Crown Bioscience

Crown Bioscience Expands Singapore Facility with Advanced Oncology Models and Imaging Capabilities
From Crown Bioscience
Via Business Wire
Crown Bioscience Partners with CTI to Support Consulting Services in Oncology Drug Development
From Crown Bioscience
Via Business Wire
Crown Bioscience Achieves CAP 15189 Accreditation; ISO 15189 Standard for Quality Medical Laboratory Services
From Crown Bioscience
Via Business Wire
Crown Bioscience Announces New Preclinical and Translational Oncology Data Across Ten Poster Presentations at AACR 2024
From Crown Bioscience
Via Business Wire
Crown Bioscience's Global Oncology Research Facilities Achieve Prestigious ISO and CAP Accreditations
From Crown Bioscience
Via Business Wire
Crown Bioscience Introduces OrganoidXplore: Revolutionizing Cancer Research with Rapid Large-scale Organoid Drug Screening
From Crown Bioscience
Via Business Wire
Indivumed Services’ Hamburg Site Receives College of American Pathologists (CAP) Accreditation
From Crown Bioscience
Via Business Wire
Crown Bioscience Enables HanX Biopharmaceutical to Progress HX009 to Clinical Trials
From Crown Bioscience
Via Business Wire
Crown Bioscience Announces Transaction Closing of Indivumed’s Service Business and Supporting Biobank
From Crown Bioscience
Via Business Wire
Crown Bioscience Opens Singapore Laboratory and Establishes Local Commercial Partner
From Crown Bioscience
Via Business Wire
Crown Bioscience to Acquire Indivumed’s Service Business and Supporting Biobank
From Crown Bioscience
Via Business Wire
Crown Bioscience Publishes New Study in PLOS ONE Highlighting the Use of Clinically Relevant 3D In Vitro PDX-Derived Organoid Models as Powerful Tools to Accelerate Cancer Drug Discovery
From Crown Bioscience
Via Business Wire
Crown Bioscience Appoints Michael Prosser as Chief Business Officer and Illustrates Further Investment in Commercial Leadership
From Crown Bioscience
Via Business Wire
Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels
From Crown Bioscience
Via Business Wire
CrownBio Acquires OcellO B.V. to Expand Its Preclinical In Vitro Drug Development Service Offerings
From Crown Bioscience
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.